Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial.
| Author | |
|---|---|
| Abstract |
:
The AspireAssist is the first Food and Drug Administration-approved endoluminal device indicated for treatment of class II and III obesity. |
| Year of Publication |
:
2019
|
| Journal |
:
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
|
| Volume |
:
15
|
| Issue |
:
8
|
| Number of Pages |
:
1348-1354
|
| ISSN Number |
:
1550-7289
|
| URL |
:
https://linkinghub.elsevier.com/retrieve/pii/S1550-7289(18)31266-8
|
| DOI |
:
10.1016/j.soard.2019.04.026
|
| Short Title |
:
Surg Obes Relat Dis
|
| Download citation |
